Testing effectiveness (Phase 2)Study completedNCT02273661
What this trial is testing
Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
Who this might be right for
Allergic Bronchopulmonary Aspergillosis
Poitiers University Hospital 174